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Extracellular volume quantitation using Dual-energy CT in patients with heart failure: 
comparison with 3T cardiac MR 
 
Abstract  
Backgrounds:  Cardiac magnetic resonance (CMR) T1 mapping and the extracellular 
volume (ECV) have been developed to quantitative analysis of diffusely abnormal 
myocardial fibrosis (MF). However, dual-energy CT (DECT) has a potential for calculation 
of ECV. The aim of this study is to evaluate the feasibility and accuracy of DECT 
technique in determining the ECV in patients with heart failure, with 3T CMR as the 
reference. 
Methods: Thirty-five patients with various reasons of heart failure were enrolled in this 
study. Both DECT and CMR exams were completed within 24 hours. ECVs were 
calculated, and the relationship between DECT-ECV, CMR-ECV, and other heart function 
parameters, including left ventricular end systolic and diastolic volume, cardiac output 
and ejection fraction (LVESV, LVEDV, CO, LVEF), Brain natriuretic peptide BNP ) was 
determined. ll participants gave informed consent, and the study was approved by the 
institutional review board.  
Results: The median ECVs on DECT and CMR were 33% (95%CI: 32%-36%) and 30% 
(95%CI: 30% - 32%), respectively. A good correlation between myocardial ECV at DECT 
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and that at CMR (r=0.945, p<0.001) was observed. Bland-Altman analysis between DECT 
and CMR showed a small bias (2.6 %), with 95% limits of agreement of -0.4% and 5.6%. 
Interobserver agreement for ECV at DECT was excellent (ICC = 0.907). Both ECVs, for 
DECT and CMR, were inversely associated with LVEF and CO. 
Conclusion: DECT-based ECV could be an alternative non-invasive imaging tool for 
myocardial tissue characterization. However, overestimation of the extent of diffuse MF 
is observed with use of DECT. 
Key words: heart failure; diffuse myocardial fibrosis; dual-energy CT; cardiac MR; 
extracellular volume 
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1. Introduction  
Myocardial fibrosis (MF) occurs in a wide variety of heart conditions including 
heart failure with reduced or preserved ejection fraction (EF), diabetic and hypertensive 
heart disease, and non-ischemia cardiomyopathies. MF may represent a principal 
phenotype of cardiac vulnerability that improves risk stratification. Moreover, MF 
quantification is associated with cardiac outcomes [1, 2]. Endomyocardial biopsy is 
widely recognized as the “gold standard” for diagnosis of MF. However, its application is 
limited in the routine clinical practice given its intrinsic issues, such as invasive and 
serious complications. Recently, T1 mapping using cardiac magnetic resonance (CMR) 
imaging has been established as a reliable technique to quantify diffuse MF [2, 3]. CMR-
derived extracellular volume fraction (ECV) calculated from native and contrast T1 maps, 
enables assessment of the extent of diffuse myocardial fibrosis [2]. CMR-derived ECV 
using T1 mapping has been validated in animal and human studies [4-6], including in 
patients with heart failure secondary to non-ischemic and ischemic cardiomyopathies, 
valve disease, cardiac amyloidosis and hypertrophic cardiomyopathy. However, CMR 
exam is not widely available and has some known contraindications. A recent published 
study showed that 5775 (16.7%) out of 34587 patients had failed MR exams because of 
unanticipated issue [7]. Moreover, the calculated ECV value is influenced by MR field 
strength, which is well documented that ECV value calculated from 3T MR are 
substantially different from that of 1.5 T MR[8]. 
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Cardiac computed tomography (CCT) has been widely used in the clinical work-
up of cardiac patients and can accurately measure myocardial perfusion [9, 10] and focal 
myocardial scarring [11]. In recent human studies [12, 13], CCT-derived ECV has 
demonstrated the ability to detect diffuse MF, with higher inter- and intra-observer 
reproducibility [14]. Although CCT has higher temporal and spatial resolution than CMR, 
it is less sensitive than CMR in terms of contrast resolution. Advanced dual source dual-
energy CT (DECT) offers the possibility of tissue characterization using 2 different kV 
levels. DECT has been shown the potential for measuring ECV in both animal and 
humans studies [15, 16]. However, it is unclear that whether DECT could measure 
diffuse MF in heart failure patients. Therefore, the aim of this study is to evaluate the 
feasibility and accuracy of DECT derived -ECV for the assessment of diffuse MF in heart 
failure patients, compared with 3T CMR derived ECV, which is regarded as the reference 
method. 
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2. Methods 
2.1 Study population 
This was a single-center study approved by the local institutional review board. 
All participants gave written informed consent and completed both the DECT and CMR 
examinations within 24-hours. From December 2016 to October 2017, 35 patients with 
clinically diagnosed HF were prospectively enrolled in this study. The included heart 
failure patients were those with New York Heart Association (NYHA) grade II or higher, 
in addition to left ventricular ejection fraction (LVEF) <35% or HF with persistent 
LVEF >50%. Hematocrit and blood BNP measurements were performed within a 24-hour 
interval of the DECT and CMR exams. Exclusive criteria included: allergy to iodine; renal 
failure (glomerular filtration rate, GFR < 60 mL/min); pregnancy; patients with stent or 
CABG (coronary artery bypass graft). 
2.2 DECT scan protocol and DECT-ECV analysis 
All patients were examined with a second generation dual-source CT (Somatom 
Definition Flash, Siemens Healthcare, Forchheim, Germany). The CCT exam protocol 
included a prospective ECG-gated calcium score acquisition, a prospective ECG-gated 
coronary CT angiography (CCTA), and a delay DECT scan. The DECT scan was run after a 
7-minute delay. For the prospective ECG-gated CCTA, the tube potential was selected 
based on the patient’s body mass index (BMI) and the tube current was modulated by 
automatic exposure control. The setting for patients with a BMI<24 kg/m2 were 100 kV, 
and the setting for patients with a BMI  ≥ 24 kg/m2 were 120 kV. Bolus-tracking was 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
performed with a region of interest (ROI) placed in the root of the aorta, and image 
acquisition was automatically started 6 s after a predefined threshold of 100 HU was 
reached. The scanning range was set from the tracheal bifurcation to the diaphragm. 
Delayed post-contrast DECT was obtained with the following scan parameters: 185 
effective mA at 100 kV, and 157 effective mA at 140 kV with a Sn filter, 64 ×0.6 mm 
collimation, 0.32 pitch factor, and 0.28 s rotation time. The effective radiation dose of 
CT was calculated by multiplying the dose-length product by a conversion factor of 
0.014 [17]. 
The contrast agent was injected with a dual-head power injector (Stellant D, 
Medrad, Indianola, PA, USA) through an 18 G intravenous needle placed in the right 
antecubital vein. Depending on the scan time, 60-90 ml of contrast agent (Ultravist, 370 
mg iodine/ml, Bayer, Wayne, NJ, USA) was injected, followed by 30 ml of saline as a 
bolus chaser. The injection rate was 4.5-5 ml/s for all phases. 
 
2.3 Dual-energy CT data post processing  
DECT post-processing was performed on a commercially available workstation 
(Syngo MMWP; Siemens Medical Solutions, Forchheim, Germany) using dedicated 
“Heart PBV (perfused blood volume)” software. First, DECT data was loaded into the 
Heart PBV. The software constructs iodine maps based on the material decomposition 
method, showing the distribution of iodine in the entire left ventricle myocardium. All 
iodine maps were reconstructed in short axis view from base to apex of heart with 8 
mm slice thickness without any gap.  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
2.4 Dual-energy CT ECV measurement 
Two observers selected iodine map images that matched the CMR T1 mapping 
images and measured independently. Overlay attenuation values of the myocardium 
and blood pool were obtained from the iodine maps. Depending on the 16-segment of 
LV myocardium (excluding 17th apex segment), ROIs were drawn manually in each 
segment in a conservative manner to avoid the periphery of the myocardium. At the 
same slice, a manual ROI with a minimum size of 100 mm2 was drawn in the LV blood 
pool and papillary muscles were avoided (Fig 1). The DECT-E V was calculated as follows: 
ECVDECT = (HUm/HUb) * (1-hematocrit level) *100%, where HUm is the attenuation value 
(Overlay value) of the myocardium (in Hounsfield units) and HUb is the attenuation value 
(Overlay value) of blood (in Hounsfield units) [15, 16]. 
2.5 Cardiac MR Protocol and CMR-ECV analysis 
All CMR exams were performed on a 3T MR scanner (Verio; Siemens, Erlangen, 
Germany) with a 32-channel cardiovascular array coil (Vivo, Orlando, Fla). An 11-heart-
beat modified Look Locker sequence with inversion recovery (MOLLI) was used for 
cardiac MR imaging T1 measurement, as described previously [2,3]. Scanning 
parameters were as follows: repetition time msec/echo time msec/minimum inversion 
time msec, 1.9/1.0/110.0; inversion time increment, 80.0 msec; field of view, 290–360 
mm2; pixel size, 1.7 × 1.4 mm2; readout resolution, 192; phase resolution, 75%–85%; 
section thickness, 8 mm; 35°flip angle; and generalized auto calibrating partially 
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parallel acquisition factor, 2. Short-axis images were acquired at the basal, mid-ventricle, 
and apical level of the LV.  
Images for T1 measurements were obtained pre- and post- intravenous infusion 
of GA-DTPA (0.2 mmol/Kg, Magnevist; Bayer Healthcare Pharmaceuticals, Wayne, NJ) 
injected as a bolus at a rate of 0.15-0.2mL/sec/kg and followed by a 20-mL saline flush. 
Post-contrast examinations were performed at the same positions as pre-contrast 
examinations 15-20 minutes after the injection of contrast agent. Steady state free 
precession cine MR short-axis images were acquired for assessment of left ventricular 
function parameters (LVESV, LVEDV, and LVEF). Late gadolinium enhanced (LGE) MR 
imaging was performed 10 minutes after injection to detect local MF. 
            All CMR images were transferred to a dedicated workstation for image analysis 
(Siemens). The ROIs were placed comparable with the DECT images on both pre-
contrast and post-contrast T1-mapping images at each segment of LV. The T1 LV blood 
pool value was measured a circular ROI (100 mm2), excluding the papillary muscles 
(Figures 1). The ECV fraction was calculated as follows: ECVCMR = ΔT1M)/ ΔT1B*(1-
HcT)*100% [2,3], ΔT1M= T1 post-contrast Myocardium -T1-pre-contrast Myocardium, 
ΔT1B= T1 post-contrast Blood -T1-pre-contrast Blood. 
 
2.6 Statistical analysis 
All statistical analyses were performed using statistical software (Medcalc 15.8,). 
Continuous variables are described as median (95% CI for median) because of no normal 
distribution. Comparison of ECV between CMR and DECT was assessed using the 
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Wilcoxon test. The correlation and the agreements between DECT-ECV and CMR-ECV 
were described with the Pearson test and the Bland-Altman plots, respectively. The 
correlation between DECT-ECV and left ventricular function parameters using CMR and 
BNP was assessed using linear correlation. Interobserver agreement was tested by 
calculating the intraclass correlation coefficient (ICC). P < 0.05 is recognized as statistical 
difference.  
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3. Results 
 
3.1 Study characteristics 
            All 35 patients completed the DECT and CMR studies without any complications. 
The mean age was 59 years (range 48 – 69 years), and 14 of the patients were females. 
The patient characteristics are summarized in Table1.  
3.2 ECV:  Dual-energy CT vs. CMR 
A total of 560 segments from 105 ECV maps were obtained at base, mid and 
apical levels from the DECT images in 35 patients. Ultimately, 75 segments were 
excluded from 15 ECV maps because of step artifacts and, 82 segments were excluded 
from 25 ECV maps because of focal LGE on DECT, resulting in 403 segments from 65 ECV 
maps analysis. Regarding CMR data was available for 75 out of 105 ECV maps. Excluding 
112 segments from 30 ECV maps because of focal LGE, a total of 448 segments from 75 
ECV maps were analyzed.  
3.3 Correlation DECT-derived ECV and CMR-derived ECV between LV function parameters 
and BNP  
The median ECVs on DECT and CMR were 33% (95%CI: 32%-36%) and 30% (95%CI: 30% - 
32%), respectively. DECT-derived ECV values were higher than that of CMR (33% vs. 30%, 
p=0.009). The Bland-Altman plots between CMR-derived ECV and DECT-derived ECV 
were presented in Figure 2. The Bland-Altman plot shows a small bias (2.6 %) toward 
higher ECV at DECT, with 95% limits of agreement of 5.6 % and -0.4%. The average 
radiation dose of DECT was 4.21 ± 1.05 mSv.  
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ECV values showed good correlation between the CMR and DECT determined 
ECV values (r=0.945, p<0.001). Both ECVs were inversely associated with LVEF and CO 
and showed a poor correlation with blood BNP (Table2).  The inter- observer agreement 
for DECT ECV showed excellent agreement with an ICC of 0.907.  
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4. Discussion  
 
In this study, we assess the performance of ECV derived from DECT for 
quantifying the diffuse MF in heart failure patients. Our results demonstrated that 
DECT-ECV could provide a reliable and accurately quantitative assessment of diffuse MF 
with good inter-observer agreement.  
Similar to CMR determined ECV, CT determined ECV quantification requires 
image acquisitions pre- and post-contrast to determine the iodine concentration 
equilibrium in the myocardium and blood pool. When contrast-agent concentration 
equilibrium is equal in both the myocardium and the blood pool, myocardial ECV can be 
calculated through the known volume of distribution in blood (1-hematocrit).  In a 
previous study, the feasibility of single energy cardiac CT (SECT) was developed to 
determine myocardial ECV through pre- and post-contrast cardiac CT scans; and its 
accuracy has been demonstrated [13]. And a good correlation was also shown between 
myocardial ECV measured with SECT and with CMR (r = 0.73) and histology (r=0.71) [12]. 
However, SECT has its inherent limitation with mismatch between pre- and post- 
contrast scans. The reason being that the lower spatial resolution of cardiac CT creates 
difficultly in differentiating myocardium and blood pool on pre-contrast CT scan [13]. 
 
In DECT, images with two different kV and mA settings were acquired 
simultaneously and were used to separate iodine and soft tissue based on different 
materials attenuation profiles [18]. Subsequently, the iodine distribution equilibrium in 
myocardium and blood pool after contrast can be measured using the iodine map from 
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the delayed scan. This method avoids the mismatch error of drawing ROIs at different 
positions caused by the separate acquisition using SECT.  Hong et al. [15] reported on 
the novel use of DECT to characterize myocardial tissue changes in an animal model of 
doxorubicin-induced cardiomyopathy. Based on the iodine maps of the myocardium and 
blood pool, their result showed that ECV calculating from DECT has excellent agreement 
with histological (r=0.925) and CMR determined ECV(r=0.888). However, DECT 
determined ECV was slightly overestimated compared to CMR determined ECV (average 
overestimation of 3%-6%). This overestimation is also shown in the results of the Nacif 
et al’s study [13]. This overestimation of DECT (33% DECT ECV vs. 30% CMR ECV) was 
also observed in our study with CMR ECV as a reference. A small bias (2.6%) toward 
higher ECV was detected for DECT (Fig 2). Possible explanations for this are as follows: 
first, the mean value from Overlay Iodine map images overstates the iodine 
concentration in both myocardium and blood pool, leading to elevated DECT ECV value; 
second, the inherent shortcoming of CT technique, such as lower soft tissue contrast 
resolution, can result in an overestimation.  
 
Increased CMR ECV was associated with left ventricle remodeling [19]. In a study 
by Nacif et al., EDV and ESV were positively correlated with SECT derived ECV, while EF 
was inversely correlation [13]. Our study showed an inverse correlation between 
LVEF/CO and both ECVs, which is clearly understood. However, the correlation between 
LV remodeling markers (EDV, ESV), serum biomarker (BNP) and DECT-ECV was poor.   
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In SECT ECV studies, the time-delay was 10 minutes to 25 minutes after contrast 
injection [12, 13]. In a previous DECT study, the time delay was set at 12-minutes after 
iodine contrast agents injection[16]. In an animal study, the time-delay was set at 3, 7, 
10, 15 and 20 min, revealing no significant changes in the DECT ECV results [15].  
According to these results, the time-delay should not influence the calculated ECV 
values. Thus, combined with results from a previous study about detecting the local 
myocardial scars [5], the time-delay of DECT was chosen at 7 minutes delay time in our 
study.    
Regarding the contrast injection, there are two different injection methods (one 
phase bolus injection and bolus followed infusion injection) in published SECT or DECT 
studies. The one phase bolus injection is a predominant method in current studies.  
However, contrast bolus followed infusion protocol was considered acceptable in 
Bandula et al study [12]. Until now, there are no documents to support which contrast 
injection methods is superior for calculating myocardial ECV. However, the main 
shortcoming of last injection method was using relatively big volume of iodine contrast 
(143.2 ± 22.7 mL). 
 
Another issue of concern is the radiation dose using DECT. In this study, the 
average radiation dose was 4.21 mSv, which is higher than both the pre- and post-
contrast SECT acquisition protocol radiation dose (average 1.98 mSv) when using the 
retrospective ECG-gating protocol. A prospective ECG-gating protocol for DECT 
acquisition is available, which promises to significantly reduce the radiation exposure. 
However, in our pre-test data, the step artifacts were clearly present through the long-
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axis, short-axis and four-chamber views of the LV, which seriously undermines the 
image quality and decreases the accuracy of the DECT ECV measurements.  
5. Study limitations 
 
This study has several limitations. First, this is a single center prospective study. 
A lack of normal ECV value, measured in healthy volunteers is rarely available in both 
DECT and CMR exam at the relatively short time interval. Second, the HCT value 
influences the calculation of ECV in both of DECT and CMR.  Collecting HCT twice at 
different examination days was not possible for each patient.  Therefore, it was aimed 
to perform both DECT and CMR on the same day.   Third, this study included relatively 
small volume of patient population. The results should therefore be validated in a larger 
cohort. 
6. Conclusion  
 
In summary, the findings of this study confirm that DECT derived ECV provides a 
good agreement of measurement in diffuse MF to CMR imaging, although DECT may 
slightly overestimate the ECV value. Given the increasing importance of cardiac CT, this 
work is exciting in its potential to provide a much more efficient, accurate, and widely 
available noninvasive measure of myocardial tissue characteristics, especially in patient 
with contraindications to CMR.  
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Figure 1 
Iodine map shows measurement of myocardial ECV with overlay attenuation values (in 
Hounsfield units). In this patient, a 63-year-old woman with HF, the overlay attenuation 
value is 25 HU for the anterior wall , 25.8 HU for the anteroseptal wall, 27.5 HU for the 
inferior-septal wall, 32.4 HU for the inferior wall, 27.2 HU for the inferior-lateral wall 
and 29.6 HU for the lateral wall of the mid left ventricle. The overlay attenuation value 
for blood is 47.1 HU, and the serum hematocrit level of the patient is 37.8%. From these 
values, the myocardial ECV is calculated as 31.83% for the anterior wall and 44.88% for 
the anteroseptal wall of the mid left ventricle. On MR images, the myocardial ECV is 
32.46% for the anterior wall and 43.12% for the anteroseptal wall. 
 
Figure 2   
Bland-Altman plot shows a small bias (2.6%) toward higher ECV at DECT (black line), 
with 95% limits of agreement between the two methods of 5.6% and -0.4% (thick gray 
lines).  
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            Table1  Basic characteristics of participants 
 Variable 
Age 59 years 
Gender 21 male, 14 female 
Body mass index (BMI) 25.30 ± 2.14 
Ischemia cardiomyopathies 9 (26%) 
Dilated cardiomyopathies  20 (57%) 
Hypertensive heart disease 5 (14%) 
Noncompaction of left ventricular 
myocardium 
1 (3%) 
Heart failure with New York Heart 
Association (NYHA) 
 
       NYHA I 0 
       NYHA II 16 (46%) 
       NYHA III 14 (40%) 
       NYHA IV 5 (14%) 
Hematocrit level (%) 45 ± 4 
BNP 1687 ± 1449 
Cardiac function parameters  
      LVEF (%) 18 ± 9.51 
      LVEDV (ml) 220 ± 78 
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      LVESV (ml) 186 ± 82 
      LV CO (ml/kg/min) 2.75 ± 1.40 
DECT effective radiation dose (mSv) 4.21 ± 1.05 
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Table 2  Correlation between both ECVs and cardiac function parameters and BNP 
 R value at DECT-ECV P value R value at CMR-ECV P value 
LVEF -0.392 0.035 -0.412 0.002 
EDV 0.138 0.491 0.145 0.469 
ESV 0.194 0.332 0.203 0.309 
CO -0.462 0.011 -0.393 0.034 
BNP 0.032 0.936 0.060 0.824 
 
 
 
 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
Highlights 
1. Higher ECV occurred in heart failure patients 
2. DECT could be an alternatively, reliably non-invasive imaging tool for myocardial 
tissue characterization 
3. Both ECVs, for DECT and CMR, were inversely associated with LV EF and cardiac 
output 
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